SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-19-283778
Filing Date
2019-11-05
Accepted
2019-11-04 21:58:33
Documents
4
Period of Report
2019-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d825269d8ka.htm 8-K/A 18687
2 EX-99.1 d825269dex991.htm EX-99.1 31043
3 GRAPHIC g825269g1101045330481.jpg GRAPHIC 4049
4 GRAPHIC g825269g1102062429914.jpg GRAPHIC 2355
  Complete submission text file 0001193125-19-283778.txt   60038
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 810930882 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38210 | Film No.: 191191587
SIC: 2836 Biological Products, (No Diagnostic Substances)